The CRO Market Outlook

Emerging Markets, Leading Players and Future Trends

Publication Date	August 2009
Publisher	Business Insights
Product Type	Report
Pages	167
ISBN Number	not applicable
Product Code	RBI00318

Buy this product or for assistance call +44 20 7060 7474

PDF £2,305.00$3834 | €2580

FAX Order above formats by FAX

Summary

Rising costs and falling productivity, among other trends are driving pharmaceutical companies to outsource an increasing range of functions to CROs in search of time and cost savings. This produced strong double-digit growth in the sector between 2003 and 2008. However, amongst other resistors, the financial crisis resulted in reduced funding available for biotech companies. This fully updated CRO Market Outlook assesses the market drivers and resistors and predicts the effects of these. The report analyzes the overarching trends in the industry; examines which regions are set to see growth in CRO activity; evaluates the leading CROs; and outlines the future of the industry. The report provides insight into conditions into seven emerging regions including China, India and Latin America. It highlights the evolving business and relationship models between CROs and sponsor companies and enables optimal outsourcing strategy.

Content

Executive Summary
- The global contract research organization market
- CRO market analysis
- Established regions in the global CRO market
- Emerging regions in the global CRO market
- Leading players in the global CRO market
- The future of contract research
Chapter 1 The global contract research organization market
- Summary
- Introduction
- The CRO contribution to drug development
- Market overview
- Key market drivers
- Key market restraints
- Conclusions and key findings
- Overview of the global CRO market
- Total revenue forecasts
- Global R&D expenditure and CRO market size
- Global clinical development outsourcing
- The contribution of CRO to drug development
- Current market drivers
- Growth of R&D expenditure from biotech and pharma
- Cost pressures encourage R&D outsourcing
- Long term growth and R&D expenditure of biotechnology companies
- Growing regulatory burden and safety concerns
- US
- EU
- Patient recruitment
- Increasing number of products in development
- The development of biomarkers
- Current market restraints
- Near term reductions in biotech R&D spending
- Growing competition and customer consolidation
- New financial realities alter biopharmaceutical outsourcing landscape
- Shortage of clinical research personnel
- Electronic data capture: a threat to CRO revenue
- Key market trends
- Globalization
- EDC evolution
- Strategic alliances
Chapter 2 CRO market analysis
- Summary
- Introduction
- Market conditions
- Competitive analysis
- Market share analysis
- Competitive dynamics
- Academic medical centers
- Site management organizations
- Laboratory analytical services
- Non-CRO niche service providers
- Conclusion
- CRO service models
- Introduction
- The full service model
- SWOT analysis
- The niche model
- SWOT analysis
- Industry strategies
- Consolidation: Mergers & acquisitions in the CRO industry
- Expanding the continuum of services: vertical integration
- Forward integration
- Backward integration
- Industry challenges
- Consolidation within the CRO industry: a threat to close customer relationships
- Strategic outsourcing: demonstrating clear value to clients
- Co-development: sharing the risk
Chapter 3 Established regions in the global CRO market
- Summary
- Introduction
- The US CRO market
- Overview
- Drivers of the US CRO market
- Challenges of the US CRO market
- Competitive dynamics
- The CRO market in Western Europe
- Overview
- Infrastructure and local regulations
- Drivers of the CRO market in Western Europe
- Challenges of the CRO market in Western Europe
- Competitive dynamics
Chapter 4 Emerging regions in the global CRO market
- Summary
- Introduction
- The Central and Eastern European CRO market
- Overview
- Infrastructure and local regulations
- Benefits of outsourcing to CEE
- Challenges of outsourcing to CEE
- Competitive dynamics
- The CRO market in China
- Overview
- Infrastructure and local regulations
- Benefits of outsourcing to China
- Challenges of outsourcing to China
- Competitive dynamics
- The CRO market in India
- Overview
- Infrastructure and local regulations
- Intellectual property
- Legislative reforms
- Benefits of outsourcing to India
- Challenges of outsourcing to India
- Competitive dynamics
- The CRO market in Latin America
- Overview
- Infrastructure and local regulations
- Argentina
- Brazil
- Mexico
- Benefits of outsourcing to Latin America
- Challenges of outsourcing to Latin America
- Competitive dynamics
- The CRO markets in South Korea and Turkey
- Overview
- Infrastructure and local regulations
- Benefits of outsourcing to South Korea
- Challenges of outsourcing to South Korea
- Benefits of outsourcing to Turkey
- Challenges of outsourcing to Turkey
- Competitive dynamics
Chapter 5 Leading players in the global CRO market
- Summary
- Introduction
- The client perspective
- Capabilities of leading CROs
- Quintiles Transnational Corp
- Company profile
- Business description
- Partnering collaborations and recent deals
- Covance
- Company profile
- Business description
- Partnering collaborations and recent deals
- PPD Inc
- Company profile
- Business description
- Partnering collaborations and recent deals
- Charles River Laboratories
- Company Profile
- Business description
- Partnering collaborations and recent deals
- PAREXEL International
- Company profile
- Business description
- Partnering collaborations and recent deals
- ICON plc
- Company profile
- Business description
- Partnering collaborations and recent deals
- MDS Inc
- Company profile
- Business description
- Partnering collaborations and recent deals
- Kendle International
- Company profile
- Business description
- Partnering collaborations and recent deals
- PRA International
- Company profile
- Business description
- Partnering collaborations and recent deals
- PharmaNet Development Group
- Company profile
- Business description
- Partnering collaborations and recent deals
Chapter 6 The future of contract research
- Summary
- Introduction
- The shift towards a strategic model
- Emerging markets
- Phases I and IV growth activity
- Electronic data capture
- Biomarkers
- Selected acquisitions/partnerships
- Conclusion
- Key findings and conclusions
Chapter 7 Appendix
- Selected bibliography
- Index
List of Figures
- Figure 1.1: Estimated CRO market ($bn), 2003-2015e
- Figure 1.2: Global development expenditure and CRO market forecast ($bn), 2008-2014e
- Figure 1.3: CRO usage and number of days by which projects overrun
- Figure 1.4: Global pharmaceutical R&D expenditure ($bn), 2000-2014e
- Figure 1.5: Number of FDA approvals 1990-2008
- Figure 1.6: Comparison of drug development cost estimates
- Figure 1.7: Global biotech R&D expenditure ($bn), 2004-2012e
- Figure 1.8: Number of products in development by phase 1998-2009
- Figure 1.9: CRO/Sponsor relationship models
- Figure 2.10: Market share of major players, 2008
- Figure 2.11: Typical full service CRO model
- Figure 3.12: R&D expenditures of PhRMA members and non-member companies ($bn), 1980- 2009
- Figure 3.13: Overall indexed clinical trial costs by region, 2006-2008
- Figure 3.14: The European CRO market ??